Sign in
Proliferative Diabetic Retinopathy with Choroidal Effusion Status Post PRP
Manish Nagpal, MD, FRCS (UK) ,FASRS
Retina Image Bank: Images of the Week
2020
Masked Safety Data from ZETA-1, an Ongoing 24-Week Phase 2 Clinical Trial of APX3330, an Oral Therapeutic Being Developed for the Treatment of Diabetic Retinopathy
Michael J Allingham, MD, PhD
Annual Meeting Talks
2022
Abicipar Phase 2 MAPLE Trial Supports Improved Safety for Patients with nAMD Following a Modified Manufacturing Process
Raj K. Maturi, MD
Updates from the Field
2019
Category: Diabetic Retinopathy